July 2026
The AI Discovery Awards are a core part of Nebius’ commitment to supporting startups develop AI apps in healthcare and life sciences.
June 2026
New vaccine technology created with the help of AI could provide immunity against whole families of viruses and protect from any future mutations.
June 2026
AI has been used to develop a “fundamentally new” type of vaccine that could protect against large swathes of viruses and prevent pandemics.
May 2026
Researchers warn funding cuts have left the country vulnerable to the deadly virus and say a vaccine is potentially just months away.
June 2025
Our Next-Generation Influenza vaccines have now demonstrated efficacy and safety in animal models and are ready for human trials.
April 2025
This bilateral project is supported by Innovate UK and Enterprise Singapore, as part of the UK-Singapore Collaborative R&D Call.
March 2025
This innovative technology aims to protect against a wide array of influenza strains.
January 2025
Driving the clinical development of its NextGen Influenza Vaccines invluding Bird-Flu.
October 2024
Insights from DIOSynVax CSO Jonathan Heeney at the World Vaccine Congress.
October 2024
We are thrilled to announce the appointment of Ron Moss as our new Chief Executive Officer.
March 2024
ProBioGen proudly announces a partnership with DIOSynVax Ltd to manufacture DIOS-HFVac3.
September 2023
Studies show that just one antigen can be modified to provide a broadly protective immune response in animals.
June 2022
Ambitious research project already underway aims to stamp out such viruses entirely.
April 2022
Cambridge start-up searches for next Covid jab in animal faeces.
March 2022
WHO consultation on COVID vaccines research: Why do we need a pan-sarbecovirus vaccine?
March 2022
The Secretary of State for Health and Social Care spoke at the summit on Tuesday 8 March 2022.
March 2022
A UK-made vaccine to protect people against future pandemics has received global backing.
February 2022
Covid vaccines: the race for a single shot to prevent new pandemics.
December 2021
A trial has begun of a new needle-free Covid-19 vaccine to protect against variants of the virus.
August 2021
COVID: we spoke to experts designing a single vaccine to defeat them all.
February 2021
A coronavirus vaccine being developed will aim to “take care of” future variants of the virus.
September 2020
Jonathan Heeney discusses what has been learned about how Coronavirus attacks.



























